Francelot Moise
Family Medicine · Hollywood, FLNPI 1528007721
Payments from drug & device makers
Across 79 payments — averaging $30.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$625
- AstraZeneca$347
- Coloplast$167
- Sunovion Pharmaceuticals Inc.$156
- Pfizer$127
- Johnson & Johnson$105
- plus $918 from 19 others
What the payments were for
- Food & beverage$2,444100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $625 |
| AstraZeneca | 10 | $347 |
| Coloplast | 1 | $167 |
| Sunovion Pharmaceuticals Inc. | 7 | $156 |
| Pfizer | 7 | $127 |
| Johnson & Johnson | 6 | $105 |
| Neurocrine Biosciences, Inc. | 1 | $102 |
| Exact Sciences | 4 | $87 |
| GSK | 4 | $83 |
| Bayer | 1 | $77 |
| Novo Nordisk | 4 | $77 |
| Lilly USA, LLC | 4 | $76 |
| Boehringer Ingelheim | 2 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Abbott | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Biosense Webster, Inc. | 1 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Angiodynamics, Inc. | 1 | $34 |
| Dexcom, Inc. | 1 | $23 |
| Novartis | 1 | $23 |
| Gilead | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$167
- WATCHMAN Access System$123
- INGREZZA$102
How this compares
$2,444 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 222 | $167,961 |
| JardianceEmpagliflozin | 120 | $92,831 |
| TrulicityDulaglutide | 70 | $68,136 |
| JanuviaSitagliptin Phosphate | 74 | $59,636 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 13 | $52,090 |
| EliquisApixaban | 76 | $50,594 |
| TradjentaLinagliptin | 59 | $31,367 |
| Nifedipine ErNifedipine | 650 | $19,955 |
| XareltoRivaroxaban | 16 | $19,561 |
| Tadalafil | 79 | $18,953 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $13,596 |
| LumiganBimatoprost | 40 | $12,241 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 115 | $9,257 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 39 | $9,010 |
| Clonidine | 94 | $8,188 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Symbicort | $347 | $172,466235 claims |
| Boehringer IngelheimJardiance, Tradjenta | $57 | $124,198179 claims |
| Lilly USA, LLCTrulicity | $76 | $68,13670 claims |
| GileadBiktarvy | $19 | $52,09013 claims |
| PfizerEliquis | $127 | $50,59476 claims |
| Johnson & JohnsonXarelto | $105 | $19,56116 claims |
| GSKBreo Ellipta | $83 | $13,59624 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Hollywood
- Sandro BacchelliHollywood$12.5M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.